A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden - Wikidata - awgldk - TriplyDB

A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden

A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden

http://www.wikidata.org/entity/Q34189794

about

Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment.Molecular diagnostics of myeloproliferative neoplasms.High-throughput sequencing for noninvasive disease detection in hematologic malignancies.The JAK2 gene as a protagonist in chronic myeloproliferative neoplasms.Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview.Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?

P2860

Q28076096-AC50AC3D-F23E-4082-9431-2915D5DF2DC5 Q36169641-9674ED41-7E06-4905-A0A4-B57DD4E6C145 Q38464571-8A88CC01-01A5-497D-891B-6F7CBBDB0D35 Q38672646-10702CE7-69B8-4FB6-BC18-5AE9720B258C Q42133428-76D23D64-E5B1-400D-89E2-CE2FDF6DA6ED Q43122604-C8F7F75D-E1E4-42BA-82BF-8684F083C54D Q43790968-4DA92AF1-BD75-4D73-BF11-6100A5A657D0

P2860

A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden

http://www.wikidata.org/entity/Q34189794

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

A highly sensitive quantitativ ...... ant JAK2 exon 12 allele burden

@ast

A highly sensitive quantitativ ...... ant JAK2 exon 12 allele burden

@en

A highly sensitive quantitativ ...... ant JAK2 exon 12 allele burden

@nl

type

label

A highly sensitive quantitativ ...... ant JAK2 exon 12 allele burden

@ast

A highly sensitive quantitativ ...... ant JAK2 exon 12 allele burden

@en

A highly sensitive quantitativ ...... ant JAK2 exon 12 allele burden

@nl

prefLabel

A highly sensitive quantitativ ...... ant JAK2 exon 12 allele burden

@ast

A highly sensitive quantitativ ...... ant JAK2 exon 12 allele burden

@en

A highly sensitive quantitativ ...... ant JAK2 exon 12 allele burden

@nl

P1433

Q34189794-46407CC3-9D4B-4DF7-B567-DE568B0CF631

P1476

Q34189794-B22F4C66-8899-4199-A242-6E2912C94C11

P2093

Q34189794-50DAF290-C681-4A9F-9D49-C571480ED116

Q34189794-A71501AA-01BB-4D1F-955B-B7414B398B1B

P2860

Q34189794-0EC50948-8612-4D83-87B3-367D40F4BA6C

Q34189794-12CFB857-D8C0-4EC0-80D8-B5D00A5BB7CA

Q34189794-17C73654-5566-4ABB-90EB-CB8E4813F022

Q34189794-1A0F4126-DD1C-4BEA-8EAF-7A2A09DADC27

Q34189794-1C17D44A-F8E6-430B-BA07-05A7515FD3EA

Q34189794-1F3E9A29-C555-4574-AF7D-5379BD312E65

Q34189794-2F4FDA17-AFFF-4A87-A34B-C3618E85A86A

Q34189794-3D7ADF1E-4267-45F0-AC00-35A4C3535DA3

Q34189794-4293C6C8-4258-42ED-9DCF-ECB34495E768

Q34189794-45E4CDC4-E80E-4E65-B4EF-CF5A262427E8

P304

Q34189794-ED79F980-1440-41AD-898F-3512992A788F

P31

Q34189794-073F6E50-3119-4D77-9AD4-3541A9AD375D

P356

Q34189794-AE766045-0C80-4DBB-A934-FD17417E817A

P407

Q34189794-48100ED5-6F22-4DC2-BAD5-56C21738FFD3

P433

Q34189794-AC3C4499-511E-47E8-916A-46D597ED1951

P478

Q34189794-14323071-EE93-431B-98BE-3EBAA020CF8C

P50

Q34189794-1C19AA87-93B4-474B-BAFD-511633F71655

Q34189794-76503D7C-7ECB-4EFF-A913-7EA800967BD3

Q34189794-824AB76F-1418-4AF3-8C56-6E6690805CA5

Q34189794-AE568A34-9894-4827-840A-E777D1ED3CB9

P577

Q34189794-E29C777A-9F1E-4199-A4D4-66A98EC09BBF

P5875

Q34189794-663A54A0-69E7-4CE8-8BBC-7FC8F22BC7D3

P698

Q34189794-82E9244A-C728-476B-9581-C0030D6BAA96

P932

Q34189794-8B74F382-49E5-485E-9096-24BE65DBE87E

P356

JOURNAL.PONE.0033100

P1433

P1476

A highly sensitive quantitativ ...... ant JAK2 exon 12 allele burden

@en

P2093

Caroline Hasselbalch Riley

http://www.w3.org/2001/XMLSchema#string

Maj Westman

http://www.w3.org/2001/XMLSchema#string

P2860

Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

The World Health Organization (WHO) classification of the myeloid neoplasms

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

A gain-of-function mutation of JAK2 in myeloproliferative disorders

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.

Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.

Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis.

Detection of exon 12 Mutations in the JAK2 gene: enhanced analytical sensitivity using clamped PCR and nucleotide sequencing.

P304

e33100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0033100

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Estrid Høgdall

Hans K. Hasselbalch

Ole Weis Bjerrum

P577

2012-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221689612

http://www.w3.org/2001/XMLSchema#string

P698

22403733

http://www.w3.org/2001/XMLSchema#string

P932

3293922

http://www.w3.org/2001/XMLSchema#string